This is the second head-to-head study after Eli Lilly registered its intent to carry out a Phase 3b clinical trial in April 2023 that will see the companys tirzepatide (Mounjaro) compared with Novo Nordisks semaglutide (Wegovy) 2.4mg in 700 adult participants who have obesity or overweight with weight related comorbidities without Type 2 diabetes
A 2020 study suggests that adhering to an eating plan and exercise goals resulted in nearly 7% more weight loss than taking a GLP-1 medication alone
Schwieler, L., Linderholm, K
Reduce el apetito, ralentiza el vaciado gstrico y ayuda a mantener una prdida de peso sostenida cuando se combina con cambios de alimentacin y actividad supervisados
Atualmente, aprofunda seus conhecimentos e habilidades na rea de toxicidade de novas substncias teraputicas com potencial biolgico e na definio de seus perfis de segurana
These medications are also used to treat type 2 diabetes under different names, forms, and dosages